top of page

01
Prurigo Nodularis (PN): Oral
Prurigo Nodularis phase 2 oral drug with extension study. Enrollment is currently CLOSED.

02
Prurigo Nodularis (PN): Topical
Prurigo Nodularis Phase 3 topical drug with extension study. Enrollment is currently OPEN.

03
Chronic Spontaneous Urticaria (CSU):
Chronic Spontaneous Urticaria Phase 3 oral drug with extension study. Enrollment is currently CLOSED.

04
Atopic Dermatitis (Eczema):
Atopic Dermatitis Phase 3 oral drug with extension study. Enrollment is currently CLOSED.

05
Psoriasis Scalp and Nail (With Taltz):
Psoriasis with scalp and nail involvement Phase 4 study with Taltz. Enrollment is currently OPEN.

CLINICAL TRIALS OFFERED
KNOW MORE.
DO MORE.
SERVE MORE.
bottom of page